3D Print 🧵 3Dable.ITCanada is backing bioprinting company Aspect Biosystems with 280M USD to scale its tissue therapy production. The Vancouver-based firm is developing bioengineered cellular medicines for regenerative medicine, with the multi-year funding supporting clinical development and domestic manufacturing capacity. https://3dprint.com/325004/canada-backs-aspect-biosystems-with-280m-to-scale-bioprinted-tissue-therapies/ #3Dprint #3Dprinting #Medical #Biotech #AspectBiosystems
Canada Backs Aspect Biosystems With $280M to Scale Bioprinted Tissue Therapies - 3DPrint.com | Additive Manufacturing Business
The Government of Canada is supporting bioprinting company Aspect Biosystems with a new $280 million project to help develop and manufacture its bioengineered cellular medicines. The project will run over...